Insiders Nabriva Therapeutics plc

Equities

NBRVF

IE000OZRGNV6

Market Closed - OTC Markets Other stock markets 11:44:50 2024-05-08 EDT			5-day change	1st Jan Change
0.000001 ^USD	-99.00%		0.00%	0.00%

2023	Nabriva Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
2023	Nabriva Therapeutics plc(OTCPK:NBRV.F) dropped from NASDAQ Composite Index	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Arbutus Biopharma Promotes Dr. Karen Sims to Chief Medical Officer, Hires Christopher Naftzger as Chief Compliance Officer	23-07-10	MT
Nabriva Therapeutics plc Appoints H. Michael Hogan as Chief Executive Officer	23-07-07	CI
Nabriva Therapeutics plc Appoints Dave Maggio as Chief Financial Officer	23-07-07	CI
Nabriva Therapeutics plc Appoints Christopher Naftzger as Interim Chief Executive Officer	23-01-20	CI
Nabriva Therapeutics plc Appoints Dr. Christine Guico-Pabia as Chief Medical Officer	21-10-01	CI
Nabriva Therapeutics plc Announces Changes to its Board of Directors	21-06-02	CI
Nabriva Therapeutics : WEP Clinical Expands Availability of Xenleta Named Patient Program in Partnership with Nabriva Therapeutics	21-03-25	AQ
Nabriva Therapeutics : WEP Clinical Expands Availability Of Xenleta® (Lefamulin) Named Patient Program In Partnership With Nabriva Therapeutics	21-03-24	PU
Nabriva Therapeutics Appoints Steven Gelone to Its Board of Directors	21-03-11	CI
WEP Clinical Partners With Nabriva Therapeutics for the Named Patient Supply of XENLETA®	20-07-06	CI
Nabriva Therapeutics plc Announces Resignation of Dr. Mark Corrigan from the Board of Directors	20-05-27	CI
Nabriva Therapeutics plc Announces Executive and Board Changes	18-07-24	CI
Axel Bolte, a Director of Nabriva Therapeutics plc Not to Stand for Re-Election to its Board of Directors at the 2018 AGM	18-06-19	CI
Nabriva Therapeutics plc Announces the Appointment of Jennifer Schranz as Chief Medical Officer	18-03-21	CI
Nabriva Therapeutics plc Announces Executive Changes	17-08-31	CI
Chau Khuong Intends to Resign from Board of Directors of Nabriva Therapeutics plc	17-08-11	CI
Nabriva Therapeutics plc Appoints Francesco Maria Lavino as Chief Commercial Officer	17-07-11	CI
Nabriva Therapeutics plc Announces Board Appointments	17-06-26	CI
Nabriva Therapeutics Ag Appoints Colin Broom as Board Member	17-06-26	CI
J. Peter Wolf to Resign from Nabriva Therapeutics AG as General Counsel and Corporate Secretary	17-01-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Nabriva Therapeutics plc

Equities

NBRVF

IE000OZRGNV6

Insiders

Filters